Multiplex Assays - Global Market Outlook (2017-2023)
According to Stratistics MRC, the Global Multiplex Assays market is estimated at $2.90 billion in 2016 and is expected to reach $5.09 billion by 2023 growing at a CAGR of 8.3% from 2016 to 2023. Growing demand for high throughput and automated systems will offer a significant growth opportunity over the forecast period. Some of the factors such as rising safety & efficiency of therapies, growing advantages of multiplexing over conventional assays and improving validation for biomarkers are contributing the market growth. However, huge capital investments and shortage of skilled labour are negatively affecting the market.
In recent, technological advancements in multiplex assays have the potential to appraise the difficulty of analytes, such as amino acids and proteins, in a better manner. In 2016, Merck launched Milliplex Map Equine-specific multiplex assay that can measure 27 cytokines simultaneously and delivers important information about immune response, inflammation, and general health.
Based on geography, North America commanded the largest market share followed by Europe. Furthermore, Asia Pacific is expected to grow at a fastest rate during the forecast period owing to increasing prevalence of Alzheimer patients, rise in pool of patient population and major growth in R&D activities (pharmaceuticals) across the region.
Some of the key players in this market include Randox Laboratories Ltd., Seegene Inc., Becton, Dickinson and Company, Qiagen N.V., Illumina, Inc., Luminex Corporation, Meso Scale Diagnostics, LLC, Merck KGAA, Abcam PLC, Bio-Rad Laboratories Inc. and Thermo Fisher Scientific Inc.
Technologies Covered:
In recent, technological advancements in multiplex assays have the potential to appraise the difficulty of analytes, such as amino acids and proteins, in a better manner. In 2016, Merck launched Milliplex Map Equine-specific multiplex assay that can measure 27 cytokines simultaneously and delivers important information about immune response, inflammation, and general health.
Based on geography, North America commanded the largest market share followed by Europe. Furthermore, Asia Pacific is expected to grow at a fastest rate during the forecast period owing to increasing prevalence of Alzheimer patients, rise in pool of patient population and major growth in R&D activities (pharmaceuticals) across the region.
Some of the key players in this market include Randox Laboratories Ltd., Seegene Inc., Becton, Dickinson and Company, Qiagen N.V., Illumina, Inc., Luminex Corporation, Meso Scale Diagnostics, LLC, Merck KGAA, Abcam PLC, Bio-Rad Laboratories Inc. and Thermo Fisher Scientific Inc.
Technologies Covered:
- Multiplex Arrays
- Multiplex PCR
- Protein Microarray
- Other Technologies
- Multiplex Assay Instruments
- Multiplex Assay Accessories
- Software and Services
- Multiplex Assay Consumables
- Nucleic Acid-Based Multiplex Assays
- Protein-Based Multiplex Assays
- Other Multiplex Assays
- Research & Development
- Diseases & Disorders
- Companion Diagnostics
- Other Applications
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals
- Clinical Laboratories
- Other End Users
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Product Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY
5.1 Introduction
5.2 Multiplex Arrays
5.2.1 Multiplex Bead-Based Array
5.2.2 Multiplex Planar Arrays
5.3 Multiplex PCR
5.4 Protein Microarray
5.5 Other Technologies
6 GLOBAL MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICES
6.1 Introduction
6.2 Multiplex Assay Instruments
6.3 Multiplex Assay Accessories
6.4 Software and Services
6.5 Multiplex Assay Consumables
7 GLOBAL MULTIPLEX ASSAYS MARKET, BY ASSAYS TYPE
7.1 Introduction
7.2 Nucleic Acid-Based Multiplex Assays
7.2.1 Planar Nucleic Acid Assays
7.2.2 Bead-Based Nucleic Acid Assays
7.3 Protein-Based Multiplex Assays
7.3.1 Planar Protein Assays
7.3.2 Bead-Based Protein Assays
7.4 Other Multiplex Assays
8 GLOBAL MULTIPLEX ASSAYS MARKET, BY APPLICATION
8.1 Introduction
8.2 Research & Development
8.2.1 Drug Development
8.2.2 Biomarker Discovery and Validation
8.3 Diseases & Disorders
8.3.1 Alzheimer’s Disease
8.3.2 Infectious Diseases
8.3.3 Allergies
8.3.4 Autoimmune Diseases
8.3.5 Cardiac Diseases
8.3.6 Cancer
8.4 Companion Diagnostics
8.5 Other Applications
9 GLOBAL MULTIPLEX ASSAYS MARKET, BY END USER
9.1 Introduction
9.2 Academic & Research Institutes
9.3 Pharmaceutical & Biotechnology Companies
9.4 Hospitals
9.5 Clinical Laboratories
9.6 Other End Users
10 GLOBAL MULTIPLEX ASSAYS MARKET, BY GEOGRAPHY
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 KEY DEVELOPMENTS
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 COMPANY PROFILING
12.1 Randox Laboratories Ltd.
12.2 Seegene Inc.
12.3 Becton, Dickinson and Company
12.4 Qiagen N.V.
12.5 Illumina, Inc.
12.6 Luminex Corporation
12.7 Meso Scale Diagnostics, LLC.
12.8 Merck KGAA
12.9 Abcam PLC
12.10 Bio-Rad Laboratories Inc.
12.11 Thermo Fisher Scientific Inc.
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Product Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Futuristic Market Scenario
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY
5.1 Introduction
5.2 Multiplex Arrays
5.2.1 Multiplex Bead-Based Array
5.2.2 Multiplex Planar Arrays
5.3 Multiplex PCR
5.4 Protein Microarray
5.5 Other Technologies
6 GLOBAL MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICES
6.1 Introduction
6.2 Multiplex Assay Instruments
6.3 Multiplex Assay Accessories
6.4 Software and Services
6.5 Multiplex Assay Consumables
7 GLOBAL MULTIPLEX ASSAYS MARKET, BY ASSAYS TYPE
7.1 Introduction
7.2 Nucleic Acid-Based Multiplex Assays
7.2.1 Planar Nucleic Acid Assays
7.2.2 Bead-Based Nucleic Acid Assays
7.3 Protein-Based Multiplex Assays
7.3.1 Planar Protein Assays
7.3.2 Bead-Based Protein Assays
7.4 Other Multiplex Assays
8 GLOBAL MULTIPLEX ASSAYS MARKET, BY APPLICATION
8.1 Introduction
8.2 Research & Development
8.2.1 Drug Development
8.2.2 Biomarker Discovery and Validation
8.3 Diseases & Disorders
8.3.1 Alzheimer’s Disease
8.3.2 Infectious Diseases
8.3.3 Allergies
8.3.4 Autoimmune Diseases
8.3.5 Cardiac Diseases
8.3.6 Cancer
8.4 Companion Diagnostics
8.5 Other Applications
9 GLOBAL MULTIPLEX ASSAYS MARKET, BY END USER
9.1 Introduction
9.2 Academic & Research Institutes
9.3 Pharmaceutical & Biotechnology Companies
9.4 Hospitals
9.5 Clinical Laboratories
9.6 Other End Users
10 GLOBAL MULTIPLEX ASSAYS MARKET, BY GEOGRAPHY
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 KEY DEVELOPMENTS
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 COMPANY PROFILING
12.1 Randox Laboratories Ltd.
12.2 Seegene Inc.
12.3 Becton, Dickinson and Company
12.4 Qiagen N.V.
12.5 Illumina, Inc.
12.6 Luminex Corporation
12.7 Meso Scale Diagnostics, LLC.
12.8 Merck KGAA
12.9 Abcam PLC
12.10 Bio-Rad Laboratories Inc.
12.11 Thermo Fisher Scientific Inc.
LIST OF TABLES
Table 1 Global Multiplex Assays Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Multiplex Assays Market Outlook, By Technology (2014-2023) ($MN)
Table 3 Global Multiplex Assays Market Outlook, By Multiplex Arrays (2014-2023) ($MN)
Table 4 Global Multiplex Assays Market Outlook, By Multiplex Bead-Based Array (2014-2023) ($MN)
Table 5 Global Multiplex Assays Market Outlook, By Multiplex Planar Arrays (2014-2023) ($MN)
Table 6 Global Multiplex Assays Market Outlook, By Multiplex PCR (2014-2023) ($MN)
Table 7 Global Multiplex Assays Market Outlook, By Protein Microarray (2014-2023) ($MN)
Table 8 Global Multiplex Assays Market Outlook, By Other Technologies (2014-2023) ($MN)
Table 9 Global Multiplex Assays Market Outlook, By Product and Services (2014-2023) ($MN)
Table 10 Global Multiplex Assays Market Outlook, By Multiplex Assay Instruments (2014-2023) ($MN)
Table 11 Global Multiplex Assays Market Outlook, By Multiplex Assay Accessories (2014-2023) ($MN)
Table 12 Global Multiplex Assays Market Outlook, By Software and Services (2014-2023) ($MN)
Table 13 Global Multiplex Assays Market Outlook, By Multiplex Assay Consumables (2014-2023) ($MN)
Table 14 Global Multiplex Assays Market Outlook, By Assays Type (2014-2023) ($MN)
Table 15 Global Multiplex Assays Market Outlook, By Nucleic Acid-Based Multiplex Assays (2014-2023) ($MN)
Table 16 Global Multiplex Assays Market Outlook, By Planar Nucleic Acid Assays (2014-2023) ($MN)
Table 17 Global Multiplex Assays Market Outlook, By Bead-Based Nucleic Acid Assays (2014-2023) ($MN)
Table 18 Global Multiplex Assays Market Outlook, By Protein-Based Multiplex Assays (2014-2023) ($MN)
Table 19 Global Multiplex Assays Market Outlook, By Planar Protein Assays (2014-2023) ($MN)
Table 20 Global Multiplex Assays Market Outlook, By Bead-Based Protein Assays (2014-2023) ($MN)
Table 21 Global Multiplex Assays Market Outlook, By Other Multiplex Assays (2014-2023) ($MN)
Table 22 Global Multiplex Assays Market Outlook, By Application (2014-2023) ($MN)
Table 23 Global Multiplex Assays Market Outlook, By Research & Development (2014-2023) ($MN)
Table 24 Global Multiplex Assays Market Outlook, By Drug Development (2014-2023) ($MN)
Table 25 Global Multiplex Assays Market Outlook, By Biomarker Discovery and Validation (2014-2023) ($MN)
Table 26 Global Multiplex Assays Market Outlook, By Diseases & Disorders (2014-2023) ($MN)
Table 27 Global Multiplex Assays Market Outlook, By Alzheimer’s Disease (2014-2023) ($MN)
Table 28 Global Multiplex Assays Market Outlook, By Infectious Diseases (2014-2023) ($MN)
Table 29 Global Multiplex Assays Market Outlook, By Allergies (2014-2023) ($MN)
Table 30 Global Multiplex Assays Market Outlook, By Autoimmune Diseases (2014-2023) ($MN)
Table 31 Global Multiplex Assays Market Outlook, By Cardiac Diseases (2014-2023) ($MN)
Table 32 Global Multiplex Assays Market Outlook, By Cancer (2014-2023) ($MN)
Table 33 Global Multiplex Assays Market Outlook, By Companion Diagnostics (2014-2023) ($MN)
Table 34 Global Multiplex Assays Market Outlook, By Other Applications (2014-2023) ($MN)
Table 35 Global Multiplex Assays Market Outlook, By End User (2014-2023) ($MN)
Table 36 Global Multiplex Assays Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 37 Global Multiplex Assays Market Outlook, By Pharmaceutical & Biotechnology Companies (2014-2023) ($MN)
Table 38 Global Multiplex Assays Market Outlook, By Hospitals (2014-2023) ($MN)
Table 39 Global Multiplex Assays Market Outlook, By Clinical Laboratories (2014-2023) ($MN)
Table 40 Global Multiplex Assays Market Outlook, By Other End Users (2014-2023) ($MN)
Note: Tables for North America, Europe, APAC, South America and Middle East & Africa Regions are also represented in the same manner as above
Table 1 Global Multiplex Assays Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Multiplex Assays Market Outlook, By Technology (2014-2023) ($MN)
Table 3 Global Multiplex Assays Market Outlook, By Multiplex Arrays (2014-2023) ($MN)
Table 4 Global Multiplex Assays Market Outlook, By Multiplex Bead-Based Array (2014-2023) ($MN)
Table 5 Global Multiplex Assays Market Outlook, By Multiplex Planar Arrays (2014-2023) ($MN)
Table 6 Global Multiplex Assays Market Outlook, By Multiplex PCR (2014-2023) ($MN)
Table 7 Global Multiplex Assays Market Outlook, By Protein Microarray (2014-2023) ($MN)
Table 8 Global Multiplex Assays Market Outlook, By Other Technologies (2014-2023) ($MN)
Table 9 Global Multiplex Assays Market Outlook, By Product and Services (2014-2023) ($MN)
Table 10 Global Multiplex Assays Market Outlook, By Multiplex Assay Instruments (2014-2023) ($MN)
Table 11 Global Multiplex Assays Market Outlook, By Multiplex Assay Accessories (2014-2023) ($MN)
Table 12 Global Multiplex Assays Market Outlook, By Software and Services (2014-2023) ($MN)
Table 13 Global Multiplex Assays Market Outlook, By Multiplex Assay Consumables (2014-2023) ($MN)
Table 14 Global Multiplex Assays Market Outlook, By Assays Type (2014-2023) ($MN)
Table 15 Global Multiplex Assays Market Outlook, By Nucleic Acid-Based Multiplex Assays (2014-2023) ($MN)
Table 16 Global Multiplex Assays Market Outlook, By Planar Nucleic Acid Assays (2014-2023) ($MN)
Table 17 Global Multiplex Assays Market Outlook, By Bead-Based Nucleic Acid Assays (2014-2023) ($MN)
Table 18 Global Multiplex Assays Market Outlook, By Protein-Based Multiplex Assays (2014-2023) ($MN)
Table 19 Global Multiplex Assays Market Outlook, By Planar Protein Assays (2014-2023) ($MN)
Table 20 Global Multiplex Assays Market Outlook, By Bead-Based Protein Assays (2014-2023) ($MN)
Table 21 Global Multiplex Assays Market Outlook, By Other Multiplex Assays (2014-2023) ($MN)
Table 22 Global Multiplex Assays Market Outlook, By Application (2014-2023) ($MN)
Table 23 Global Multiplex Assays Market Outlook, By Research & Development (2014-2023) ($MN)
Table 24 Global Multiplex Assays Market Outlook, By Drug Development (2014-2023) ($MN)
Table 25 Global Multiplex Assays Market Outlook, By Biomarker Discovery and Validation (2014-2023) ($MN)
Table 26 Global Multiplex Assays Market Outlook, By Diseases & Disorders (2014-2023) ($MN)
Table 27 Global Multiplex Assays Market Outlook, By Alzheimer’s Disease (2014-2023) ($MN)
Table 28 Global Multiplex Assays Market Outlook, By Infectious Diseases (2014-2023) ($MN)
Table 29 Global Multiplex Assays Market Outlook, By Allergies (2014-2023) ($MN)
Table 30 Global Multiplex Assays Market Outlook, By Autoimmune Diseases (2014-2023) ($MN)
Table 31 Global Multiplex Assays Market Outlook, By Cardiac Diseases (2014-2023) ($MN)
Table 32 Global Multiplex Assays Market Outlook, By Cancer (2014-2023) ($MN)
Table 33 Global Multiplex Assays Market Outlook, By Companion Diagnostics (2014-2023) ($MN)
Table 34 Global Multiplex Assays Market Outlook, By Other Applications (2014-2023) ($MN)
Table 35 Global Multiplex Assays Market Outlook, By End User (2014-2023) ($MN)
Table 36 Global Multiplex Assays Market Outlook, By Academic & Research Institutes (2014-2023) ($MN)
Table 37 Global Multiplex Assays Market Outlook, By Pharmaceutical & Biotechnology Companies (2014-2023) ($MN)
Table 38 Global Multiplex Assays Market Outlook, By Hospitals (2014-2023) ($MN)
Table 39 Global Multiplex Assays Market Outlook, By Clinical Laboratories (2014-2023) ($MN)
Table 40 Global Multiplex Assays Market Outlook, By Other End Users (2014-2023) ($MN)
Note: Tables for North America, Europe, APAC, South America and Middle East & Africa Regions are also represented in the same manner as above
